Literature DB >> 9261424

Cell-type-specific separate regulation of the E6 and E7 promoters of human papillomavirus type 6a by the viral transcription factor E2.

B Rapp1, A Pawellek, F Kraetzer, M Schaefer, C May, K Purdie, K Grassmann, T Iftner.   

Abstract

Gene expression of human papillomaviruses (HPV) is tightly controlled by cellular factors and by the virally encoded E2 protein through binding to distinct sites within the regulatory noncoding region. While for the high-risk genital papillomaviruses a single promoter drives the expression of all early genes, a second promoter present in the E6 open reading frame of the low-risk HPV type 6 (HPV6) would allow an independent regulation of E6 and E7 oncogene expression. In this report, we provide the first evidence that E2 regulates both early promoters of HPV6 separately and we show that promoter usage as well as E2 regulation is cell type dependent. Among the different epithelial cell lines tested, only RTS3b cells allowed an expression pattern similar to that observed in naturally infected benign condylomas. While the E6 promoter was repressed by E2 to 50% of its basal activity, the E7 promoter was simultaneously stimulated up to fivefold. Activation of the E7 promoter was mediated predominantly by the binding of E2 to the most promoter-distal E2 binding site. Repression of the E6 promoter depended on the presence of two intact promoter-proximal binding sites. Mutation of both of these repressor binding sites reversed the effect of E2 on the E6 promoter from repression to activation. In contrast, in HT3 cells we observed an E2-mediated activation of the E6 promoter in the context of the wild-type noncoding region. This indicated that repression of the E6 promoter by binding of E2 to both promoter-proximal binding sites did not function in the cellular environment provided by HT3 cells. These data suggest that the separate regulation of the E6 and E7 promoters of HPV6 is mediated through successive occupation of binding sites with different affinities for E2 depending on the intracellular concentration of E2 and on the cellular environment provided by the infected cell.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9261424      PMCID: PMC191980     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  54 in total

1.  OVEC, a versatile system to study transcription in mammalian cells and cell-free extracts.

Authors:  G Westin; T Gerster; M M Müller; G Schaffner; W Schaffner
Journal:  Nucleic Acids Res       Date:  1987-09-11       Impact factor: 16.971

Review 2.  The structure, function, and regulation of papillomaviral genes in infection and cervical cancer.

Authors:  L P Turek
Journal:  Adv Virus Res       Date:  1994       Impact factor: 9.937

Review 3.  Animal models of human-papillomavirus-associated oncogenesis.

Authors:  J L Brandsma
Journal:  Intervirology       Date:  1994       Impact factor: 1.763

4.  The E2 transcriptional repressor can compensate for Sp1 activation of the human papillomavirus type 18 early promoter.

Authors:  C Demeret; M Yaniv; F Thierry
Journal:  J Virol       Date:  1994-11       Impact factor: 5.103

5.  The human papillomavirus type 16 E2 transcription factor binds with low cooperativity to two flanking sites and represses the E6 promoter through displacement of Sp1 and TFIID.

Authors:  S H Tan; L E Leong; P A Walker; H U Bernard
Journal:  J Virol       Date:  1994-10       Impact factor: 5.103

6.  Changes in RNA expression pattern during the malignant progression of cottontail rabbit papillomavirus-induced tumors in rabbits.

Authors:  R Zeltner; L A Borenstein; F O Wettstein; T Iftner
Journal:  J Virol       Date:  1994-06       Impact factor: 5.103

7.  Comparison of the properties of the E6 and E7 genes of low- and high-risk cutaneous papillomaviruses reveals strongly transforming and high Rb-binding activity for the E7 protein of the low-risk human papillomavirus type 1.

Authors:  A Schmitt; J B Harry; B Rapp; F O Wettstein; T Iftner
Journal:  J Virol       Date:  1994-11       Impact factor: 5.103

8.  Prevalence of deletions of YY1-binding sites in episomal HPV 16 DNA from cervical cancers.

Authors:  X P Dong; F Stubenrauch; E Beyer-Finkler; H Pfister
Journal:  Int J Cancer       Date:  1994-09-15       Impact factor: 7.396

9.  A switch region determines the cell type-specific positive or negative action of YY1 on the activity of the human papillomavirus type 18 promoter.

Authors:  T Bauknecht; F Jundt; I Herr; T Oehler; H Delius; Y Shi; P Angel; H Zur Hausen
Journal:  J Virol       Date:  1995-01       Impact factor: 5.103

10.  Sequence determination of human papillomavirus type 6a and assembly of virus-like particles in Saccharomyces cerevisiae.

Authors:  K J Hofmann; J C Cook; J G Joyce; D R Brown; L D Schultz; H A George; M Rosolowsky; K H Fife; K U Jansen
Journal:  Virology       Date:  1995-06-01       Impact factor: 3.616

View more
  16 in total

1.  The E8 domain confers a novel long-distance transcriptional repression activity on the E8E2C protein of high-risk human papillomavirus type 31.

Authors:  F Stubenrauch; T Zobel; T Iftner
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

2.  Regulation of hepatitis B virus expression in progenitor and differentiated cell types: evidence for negative transcriptional control in nonpermissive cells.

Authors:  M Ott; Q Ma; B Li; S Gagandeep; L E Rogler; S Gupta
Journal:  Gene Expr       Date:  1999

3.  A novel recombinant papillomavirus genome enabling in vivo RNA interference reveals that YB-1, which interacts with the viral regulatory protein E2, is required for CRPV-induced tumor formation in vivo.

Authors:  Natalie Leiprecht; Ekaterina Notz; Johanna Schuetz; Juliane Haedicke; Frank Stubenrauch; Thomas Iftner
Journal:  Am J Cancer Res       Date:  2014-05-26       Impact factor: 6.166

4.  A transactivator function of cottontail rabbit papillomavirus e2 is essential for tumor induction in rabbits.

Authors:  Sonja Jeckel; Evamaria Huber; Frank Stubenrauch; Thomas Iftner
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

5.  CCAAT displacement protein binds to and negatively regulates human papillomavirus type 6 E6, E7, and E1 promoters.

Authors:  W Ai; E Toussaint; A Roman
Journal:  J Virol       Date:  1999-05       Impact factor: 5.103

6.  Genetic analysis of the human papillomavirus type 31 differentiation-dependent late promoter.

Authors:  Jason M Bodily; Craig Meyers
Journal:  J Virol       Date:  2005-03       Impact factor: 5.103

7.  Role of Bak in UV-induced apoptosis in skin cancer and abrogation by HPV E6 proteins.

Authors:  S Jackson; C Harwood; M Thomas; L Banks; A Storey
Journal:  Genes Dev       Date:  2000-12-01       Impact factor: 11.361

8.  Displacement of YY1 by differentiation-specific transcription factor hSkn-1a activates the P(670) promoter of human papillomavirus type 16.

Authors:  I Kukimoto; T Kanda
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

Review 9.  Involvement of Brd4 in different steps of the papillomavirus life cycle.

Authors:  Thomas Iftner; Juliane Haedicke-Jarboui; Shwu-Yuan Wu; Cheng-Ming Chiang
Journal:  Virus Res       Date:  2016-12-10       Impact factor: 3.303

10.  Identification of the E9/E2C cDNA and functional characterization of the gene product reveal a new repressor of transcription and replication in cottontail rabbit papillomavirus.

Authors:  Sonja Jeckel; Ekaterina Loetzsch; Evamaria Huber; Frank Stubenrauch; Thomas Iftner
Journal:  J Virol       Date:  2003-08       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.